ABL Bio Inc (298380) — Financial Flexibility Index
ABL Bio Inc (298380) has a Financial Flexibility Index of 0.29x as of March 2026. Free cash flow of ₩33.09 Billion (operating CF ₩32.84 Billion minus capex ₩243.74 Million) represents 0% of total liabilities (₩114.79 Billion). Check 298380 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ABL Bio Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for ABL Bio Inc across 10 annual periods. See ABL Bio Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ABL Bio Inc (2016–2025)
Year-by-year free cash flow to debt coverage for ABL Bio Inc. For the full company profile including market capitalisation, see 298380 market cap.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.17x | ₩-20.58 Billion | ₩-41.25 Billion | ₩124.24 Billion | ▲ +82.2% |
| 2024 | -0.93x | ₩-60.34 Billion | ₩-69.40 Billion | ₩64.70 Billion | ▼ -256.5% |
| 2023 | -0.26x | ₩-22.52 Billion | ₩-28.36 Billion | ₩86.07 Billion | ▼ -140.8% |
| 2022 | 0.64x | ₩74.19 Billion | ₩72.13 Billion | ₩115.67 Billion | ▲ +115.5% |
| 2021 | -4.14x | ₩-39.36 Billion | ₩-40.61 Billion | ₩9.50 Billion | ▲ +18.4% |
| 2020 | -5.08x | ₩-46.86 Billion | ₩-47.29 Billion | ₩9.23 Billion | ▼ -148.4% |
| 2019 | -2.04x | ₩-22.26 Billion | ₩-23.86 Billion | ₩10.89 Billion | ▼ -111.3% |
| 2018 | -0.97x | ₩-11.52 Billion | ₩-12.67 Billion | ₩11.91 Billion | ▼ -1522.3% |
| 2017 | -0.06x | ₩-6.34 Billion | ₩-7.14 Billion | ₩106.32 Billion | ▼ -18.7% |
| 2016 | -0.05x | ₩-985.97 Million | ₩-3.12 Billion | ₩19.63 Billion | — |